Literature DB >> 8416242

Seizure outcome in patients with surgically treated cerebral arteriovenous malformations.

D G Piepgras1, T M Sundt, A T Ragoowansi, L Stevens.   

Abstract

A series of 280 cases of cerebral arteriovenous malformations (AVM's) treated surgically between June, 1970, and June, 1989, is reviewed with particular focus on the preoperative seizure history and follow-up seizure status. Follow-up evaluation (mean duration 7.5 years) was achieved in 98% of cases and was accomplished through re-examinations, telephone interviews, and written questionnaires. Overall, 89% of the surviving patients with a follow-up period of greater than 2 years were free of seizures at last examination. Of the 280 patients in this series, 163 had experienced no seizures preoperatively. A recent follow-up study (with a minimum duration of 2 years or to death) was available in 157 of these 163 cases; 21 patients had died. Of the 136 surviving patients, only eight (6%) were having new ongoing seizures. In the 128 (94%) who had remained seizure-free, 73% were receiving no anticonvulsant agents while 27% were taking anticonvulsant prophylaxis. The 2-year minimum follow-up study in 110 of the 117 patients with preoperative seizures revealed that eight (7%) had died. Of the 102 surviving patients, 85 (83%) were seizure-free (with 48% no longer receiving anticonvulsant therapy), while 17 (17%) still suffered intermittent seizures. However, of these 17 patients, 13 reported their seizures to be improved compared to preoperatively; the seizures were the same in two patients and were worse in two patients. An actuarial analysis was conducted comparing the life expectancy of patients following surgery for AVM's with the expected survival of a general white population of the same age and sex in the West Northcentral region of the United States. No statistically significant difference was found. There were seven perioperative deaths (three from cerebral hemorrhage, two from pulmonary emboli, and two from obstruction of venous drainage) and 22 deaths during the follow-up period. Of these 22 deaths, the cause was unknown in four patients, apparently unrelated to the AVM in 13, and directly or indirectly related to the patient's neurological condition prior to surgery or due to surgery performed for resection of the AVM in five. There was a statistically significant relationship between the size and location of the AVM and the clinical presentation. Patients with small AVM's (< 3 cm) were more likely to present with hemorrhage whereas those with large AVM's were more likely to present with seizures.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8416242     DOI: 10.3171/jns.1993.78.1.0005

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  21 in total

1.  Clinical, radiological profile and outcome in pediatric Spetzler-Martin grades I-III arteriovenous malformations.

Authors:  Anup P Nair; Raj Kumar; Anant Mehrotra; A K Srivastava; Rabi Narayan Sahu; Prakash Nair
Journal:  Childs Nerv Syst       Date:  2012-01-21       Impact factor: 1.475

2.  Seizure predictors and control after microsurgical resection of supratentorial arteriovenous malformations in 440 patients.

Authors:  Dario J Englot; William L Young; Seunggu J Han; Charles E McCulloch; Edward F Chang; Michael T Lawton
Journal:  Neurosurgery       Date:  2012-09       Impact factor: 4.654

3.  Seizures after Onyx embolization for the treatment of cerebral arteriovenous malformation.

Authors:  K de Los Reyes; A Patel; A Doshi; N Egorova; F Panov; J B Bederson; J A Frontera
Journal:  Interv Neuroradiol       Date:  2011-10-17       Impact factor: 1.610

4.  Risk factors for developing epilepsy after craniotomy in children.

Authors:  Dimitris Kombogiorgas; N Shastri Jatavallabhula; Spyros Sgouros; Vivek Josan; A Richard Walsh; Anthony D Hockley
Journal:  Childs Nerv Syst       Date:  2006-05-30       Impact factor: 1.475

5.  Seizure control following treatment of brain arteriovenous malformations in pediatric patients.

Authors:  Xiangke Ma; Xianzeng Tong; Jun Wu; Yong Cao; Shuo Wang
Journal:  Childs Nerv Syst       Date:  2016-09-01       Impact factor: 1.475

6.  Brain arteriovenous malformations and endovascular treatment: effect on seizures.

Authors:  X Lv; Y Li; C Jiiang; X Yang; Z Wu
Journal:  Interv Neuroradiol       Date:  2010-03-25       Impact factor: 1.610

7.  Relief of epilepsy and headache and quality of life after microsurgical treatment of unruptured brain AVM-audit of a single-center series and comprehensive review of the literature.

Authors:  Benjamin Rohn; Daniel Hänggi; Nima Etminan; Bernd Turowski; Hans-Jakob Steiger
Journal:  Neurosurg Rev       Date:  2016-05-21       Impact factor: 3.042

Review 8.  Poststroke epilepsy: epidemiology, pathophysiology and management.

Authors:  José M Ferro; Francisco Pinto
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

9.  Arteriovenous Malformations in the Brain.

Authors:  Glenn D. Graham
Journal:  Curr Treat Options Neurol       Date:  2002-11       Impact factor: 3.598

Review 10.  Neuropsychological effects of brain arteriovenous malformations.

Authors:  Emily R Lantz; Philip M Meyers
Journal:  Neuropsychol Rev       Date:  2008-05-24       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.